-

AM Best Assigns Credit Ratings to Upstream Life Insurance Company

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned a Financial Strength Rating of B- (Fair) and a Long-Term Issuer Credit Rating of “bb-” (Fair) to Upstream Life Insurance Company (Upstream Life) (Dallas, TX). The outlook assigned to these Credit Ratings (ratings) is stable.

The ratings reflect Upstream Life’s balance sheet strength, which AM Best assesses as weak, as well as its marginal operating performance, limited business profile and appropriate enterprise risk management (ERM).

Upstream Life’s risk-adjusted capitalization is assessed at the very strong level, as measured by Best’s Capital Adequacy Ratio (BCAR). This is offset by increased reinsurance leverage and dependence on unrated reinsurers, limited financial flexibility, increased financial leverage at the holding company level and volatility in balance sheet metrics. AM Best expects Upstream Life’s risk-adjusted capitalization to remain at current levels.

Although operating results were profitable in 2023 and through second-quarter 2024, there were significant operating losses in 2019-2022. Additionally, there has been significant volatility in premium levels and operating earnings over the past five years, though results have been more consistent since the beginning of 2023.

The company is licensed in 25 states and offers a multiyear guaranteed fixed annuity product. Product diversification is somewhat limited and the companies within the annuity space face high levels of competition. While the ERM governance structure and framework has improved in recent years, the company faces significant challenges with a concentrated liability portfolio and limited financial flexibility.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2024 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Louis Silvers
Senior Financial Analyst
+1 908 882 2316
louis.silvers@ambest.com

Jacqalene Lentz
Director
+1 908 882 2011
jacqalene.lentz@ambest.com

Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com

Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com

AM Best


Release Versions

Contacts

Louis Silvers
Senior Financial Analyst
+1 908 882 2316
louis.silvers@ambest.com

Jacqalene Lentz
Director
+1 908 882 2011
jacqalene.lentz@ambest.com

Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com

Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com

More News From AM Best

Best’s Commentary: Health Insurers Evaluating Balance Between Pharmacy Costs and Long-Term Value of GLP-1 Therapies

OLDWICK, N.J.--(BUSINESS WIRE)--As pharmacy cost trends continue to rise and clinical evidence evolves, health insurers face a fundamental question on whether improvements in long-term morbidity and the potential for improved mortality outcomes ultimately justify significant investments in GLP-1 therapies, according to a new AM Best commentary. The Best’s Commentary, “GLP-1 Therapies: Evaluating the Balance Between Pharmacy Costs and Long-Term Value,” states that GLP-1 therapies have become one...

AM Best Downgrades Credit Ratings of A-CAP Group Members; Maintains Under Review With Negative Implications Status

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has downgraded the Financial Strength Rating (FSR) to C+ (Marginal) from B (Fair) and the Long-Term Issuer Credit Rating (Long-Term ICR) to “b-” (Marginal) from “bb+” (Fair) of Atlantic Coast Life Insurance Company (Charleston, SC) and Sentinel Security Life Insurance Company (Salt Lake City, UT). Both companies are collectively referred to as A-CAP Group. Concurrently, AM Best has maintained the under review with negative implications status for these Cre...

AM Best to Deliver Presentation at 2026 ACLI Annual Conference

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best will speak at the American Council of Life Insurers (ACLI) Annual Conference, which will take place Oct. 14-16, 2026, in Orlando, FL. Kenneth Frino, managing director, and Erik Miller, senior director, both of AM Best, will deliver a presentation, titled, “Life and Annuity Segment in Transition,” during which they will focus on operating results across the life/annuity segment, as well as investment strategies, rating activity trends and AM Best’s segment...
Back to Newsroom